Alnylam Pharmaceuticals
ALNY
#586
Rank
HK$267.72 B
Marketcap
HK$2,076
Share price
0.58%
Change (1 day)
44.38%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company